Startups & growth Analysis
Immunartes takes two approaches to preventing hard-to-fight staph infections
Immunartes is developing a vaccine and an antibody for different prevention needs, with both programs still in preclinical research.
Dominique Missiakas is ImmunArtes founder and Chief Scientific Officer. Vilasack Thammavongsa is current CEO and Director of Research; founder status is not inferred from that title.
Loading profile details…
Loading recent changes…
Identity sources & editorial review (1)
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
